HIV/AIDS Vaccines
Recent findings in HIV/AIDS vaccines provide new insights
Published in AIDS Weekly, June 27th, 2005
Study 1: A prime-double boost immunization strategy elicited long-lived multi-isotype anti-HIV antibody responses.
"Despite decades of work, an effective HIV vaccine remains elusive. In an effort to elicit protective immunity, investigators have sought to define vaccines able to elicit durable HIV-specific B-cell and T-cell activities. Additionally, vaccines are sought which can induce antibodies of a variety of isotypes, as each isotype possesses unique attributes in terms of opsonization, Fc receptor binding capacity, complement fixation and location,"...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2005-06-27)
More Articles from AIDS Weekly
- HIV/AIDS Diagnostics
Duplex real-time PCR assay detects HIV DNA in dried blood spots - HIV/AIDS Drug Development
Pertussis toxin B-oligomer inhibits HIV infection and replication - HIV/AIDS Epidemiology
"Surplus" men in China may become significant new HIV risk group - HIV/AIDS Infection
Apoptosis may prevent HIV-1 infection in an exposed but uninfected population - Simian Immunodeficiency Virus
Anti-inflammatory profiles protect against AIDS in early SIV infection - Antimicrobial
Hoechst 33258 active against P. carinii/C. albicans/C. dubliniensis - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
